| Trial ID: | L7154 |
| Source ID: | NCT01326533
|
| Associated Drug: |
Hydroxychloroquine
|
| Title: |
Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01326533/results
|
| Conditions: |
Pre-diabetes
|
| Interventions: |
DRUG: hydroxychloroquine|OTHER: Placebo
|
| Outcome Measures: |
Primary: Insulin Sensitivity, Change from baseline in the insulin sensitivity index (Si), 13 weeks after baseline measurement | Secondary: Beta Cell Function, Change from baseline in the disposition index (DI), 13 weeks after baseline measurement
|
| Sponsor/Collaborators: |
Sponsor: University of Pittsburgh | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2011-03
|
| Completion Date: |
2014-12
|
| Results First Posted: |
2016-01-29
|
| Last Update Posted: |
2016-02-26
|
| Locations: |
University of Pittsburgh, Montefiore Hospital, Pittsburgh, Pennsylvania, 15213, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01326533
|
